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In This IssueProgress and Challenges for Stem Cell
Therapies in Clinical Trials
TROUNSON AND MCDONALD, 11
Clinical investigations using stem cell products are addressing awide spectrum of
conditions using many different stem cell types. Trounson and McDonald review
the clinical trials in which data have now been published and highlight areaswhere
progress is being made as well as failures and areas of concern.
Aspp1: A Guardian of Hematopoietic Stem
Cell Integrity
YAMASHITA ET AL., 23
Suda and colleagues show that the hematopoietic stem cell (HSC) pool integrity is
coordinately controlled by p53 and its proapoptotic activator Aspp1. Aspp1 has
both p53-dependent and -independent functions in regulating HSC self-renewaland DNA damage tolerance, and concomitant deletion of Aspp1 and p53 in HSCs leads to hematological malignancies.
Preview by Zak and Lu.
Adaptable Blood Production from Distinct MPPs
PIETRAS ET AL., 35
Pietras et al. show that HSCs produce functionally distinct lineage-biasedMPPs that work together to adapt blood production
to hematopoietic demands. Two rare subsets of myeloid-biased MPPs are important for maintaining blood homeostasis at
steady state, and they serve as a potent source of myeloid renewal in regenerative conditions. (Top image.)
Sox9 in BCC Self-Renewal and Invasiveness
LARSIMONT ET AL., 60
Using mouse models of basal cell carcinoma, Larsimont and colleagues show that Sox9 is required for self-renewal of
oncogene-expressing cells and BCC formation. Transcriptional profiling combined with ChIP-sequencing uncovered a
cancer-specific gene network regulated by Sox9 that promotes stemness, represses differentiation, and induces ECM and
cytoskeleton remodeling required for tumor invasion.
Direct Reprogramming of RESTing Astrocytes
MASSERDOTTI ET AL., 74
Masserdotti et al. analyzed early transcriptional changes mediated by Neurog2 and Ascl1 during direct reprogramming of
murine postnatal astrocytes into distinct neuronal subtypes in vitro. This led to the identification of shared downstream tar-
gets, including NeuroD4, capable of neuronal reprogramming of fibroblasts and human astrocytes, as well as mechanistic
insight into how the repressor REST functions as a barrier in direct neuronal reprogramming. Preview by Wang et al.
Epigenetic Abnormalities in Heart Failure
WU ET AL., 89
In this paper, Wu et al. profiled the b-adrenergic signaling properties in human iPSC-CMs and demonstrated novel epigenetic
mechanisms that underlie the compromised b-adrenergic signaling in DCM, a common cause of heart failure, and cardiac
transplantation. These results enhance our understanding of DCM pathogenesis and may uncover new therapeutic targets.Tissue Memory Impacts Efficiency of iPSC-
Derived Photoreceptors
HILER ET AL., 101
Cellular therapies to treat retinal degeneration are in clinical trials but it is unclear
how the stem cell source impacts the production of differentiated cells for trans-
plantation. Hiler et al. show that iPSCs derived from retinal photoreceptors retain
retinal epigenetic memory and make retina more efficiently than fibroblast iPSCs.
Generation of Monkey Chimeric Fetuses
CHEN ET AL., 116
Chen et al. show that it is feasible to generate chimeric monkeys with contribu-
tions in all three germ layers using culture-induced naive-like state embryonic
stem cells, opening up new avenues for the use of non-human primate models
to study both pluripotency and human disease. (Bottom image.)Cell Stem Cell 17, July 2, 2015 ª2015 Elsevier Inc. ix
